Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?
Jan Storek, Julian Lindsay
Topics & Concepts
RituximabMedicinePost-transplant lymphoproliferative disorderLymphoproliferative disordersRefractory (planetary science)ImmunologyInternal medicineOncologyLymphomaIntensive care medicineAstrobiologyPhysicsViral-associated cancers and disordersPolyomavirus and related diseasesLymphoma Diagnosis and Treatment